Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

CEO exits just hit a milestone. It may be the tip of the iceberg. © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any ...

The National Interest is an award-winning online publication focusing on defense issues, national security, military affairs and hardware, foreign policy, and U.S. politics. The National Interest ...